GlassScriptPhysician profile
Paul L Manganelli
NPI 1841247236
$13,976.18
in general payments reported to CMS, 2019-2025
29 companies · $1,858 in 2025
The $1,858 reported for 2025 was more than what 77% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,404 · 2020: $770 · 2021: $880 · 2022: $756 · 2023: $2,755 · 2024: $1,554 · 2025: $1,858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,276 · Travel and Lodging: $1,891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,275.58 |
| Travel and Lodging | $1,890.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $1,912.68 | 2019 | |
| Abbott Laboratories | $1,674.93 | 2019-2025 | Proclaim |
| Boston Scientific Corporation | $1,668.83 | 2019-2025 | General - Pain Management, Intracept |
| Nevro Corp. | $1,334.31 | 2019-2024 | Senza |
| Saluda Medical Americas, INC. | $1,270.94 | 2023-2025 | Evoke Scs, Evoke |
| Medtronic USA, INC. | $1,185.11 | 2019 | |
| Globus Medical, INC. | $1,163.56 | 2025 | Vyrsa V1, Senza |
| Relievant Medsystems, INC. | $911.02 | 2023 | Intracept |
| Spr Therapeutics, INC | $529.08 | 2021-2024 | Sprint Pns System |
| Nalu Medical, INC. | $371.71 | 2022-2024 | Nalu Neurostimulation System |
| Curonix LLC | $291.81 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mml US, INC. | $235.07 | 2024 | Reactiv8 |
| Averitas Pharma INC. | $190.01 | 2024-2025 | Qutenza |
| Medtronic, INC. | $182.19 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Biotronik Nro, INC. | $182.09 | 2023-2025 | Prospera, Biotronik |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $127.26 | 2019-2022 | |
| Spinal Simplicity, LLC | $123.20 | 2023-2025 | Ha Minuteman G3-R |
| Medwest Associates | $117.00 | 2021 | |
| Tersera Therapeutics LLC | $108.32 | 2023-2025 | Prialt |
| Grt US Holding, INC. | $92.52 | 2022 | |
| Pfizer INC. | $72.03 | 2019 | |
| Si-Bone, INC. | $66.41 | 2019-2024 | |
| Orexo US, INC. | $47.06 | 2024-2025 | Zubsolv |
| Stryker Corporation | $30.68 | 2021 | |
| Depuy Synthes Sales INC. | $21.19 | 2019 | |
| Collegium Pharmaceutical, INC. | $19.33 | 2023 | Xtampza |
| Vertos Medical, INC. | $19.22 | 2024 | Mild Device Kit |
| Amgen INC. | $15.40 | 2024 | Prolia, Evenity |
| Arteriocyte Medical Systems, INC. | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Manganelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.